Trials / Unknown
UnknownNCT03834246
Smoke Inhalation Injury in Patients Admitted to Intensive Care
Prognostic Factors for Smoke Inhalation Injury in Patients Admitted to Intensive Care
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 700 (estimated)
- Sponsor
- Centre d'Investigation Clinique et Technologique 805 · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Many Studies have shown that the smoke-inhalation injury is responsible for a high mortality mainly related to the systemic effects of carbon monoxide and cyanide. Respiratory lesions induced by smoke inhalation, is one of predictive factors of mortality. The aim of the study is to identify the clinical and epidemiological characteristics of smoke-inhalation injury and to identify prognostic factors among these patients .
Detailed description
The study is a monocentric, retrospective, descriptive and analytical study , betwen december 1997 and september 2018 in intensive care unit of university of hospital. All patients aged over 18 year and who had received a diagnosis of smoke- inhalation injury and were admitted to the ICU of Medical University Hospital , a referral center in Paris providing HBO therapy , were potentially eligible for inclusion in this investigation. Criteria used for recommending HBO therapy to a patient with transient or prolonged unconsciousness, abnormal neurologic findings on physical examination. Data were analyzed to identify independent factors that may influence mortality.
Conditions
Timeline
- Start date
- 2018-10-16
- Primary completion
- 2019-12-31
- Completion
- 2020-05-31
- First posted
- 2019-02-07
- Last updated
- 2019-02-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03834246. Inclusion in this directory is not an endorsement.